scholarly journals Pathologic basis of the preferential thinning of thecorpus callosum in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)

2021 ◽  
Vol 22 ◽  
pp. 100310
Author(s):  
Michiaki Kinoshita ◽  
Kiyomitsu Oyanagi ◽  
Yasufumi Kondo ◽  
Keisuke Ishizawa ◽  
Kenji Ishihara ◽  
...  
Keyword(s):  
Adult Onset ◽  
Axonal Spheroids ◽  
Pathologic Basis

scholarly journals Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: A case report

2019 ◽  
Vol 14 (4) ◽  
pp. 514-517 ◽  
Author(s):  
Seongsu Kang ◽  
Da Mi Kim ◽  
In Ho Lee ◽  
Chang June Song
Keyword(s):  
Case Report ◽  
Adult Onset ◽  
Axonal Spheroids

Evaluation of CSF1R‐related adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria

2021 ◽  
Author(s):  
X Ayrignac ◽  
C Carra Dallière ◽  
P Codjia ◽  
K Mouzat ◽  
G Castelnovo ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Adult Onset ◽  
Axonal Spheroids

NfL is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

Neurology ◽  
2018 ◽  
Vol 91 (16) ◽  
pp. 755-757 ◽  
Author(s):  
Stefanie N. Hayer ◽  
Ilona Krey ◽  
Christian Barro ◽  
Franziska Rössler ◽  
Peter Körtvelyessy ◽  
...  
Keyword(s):  
Adult Onset ◽  
Axonal Spheroids

Sporadic Japanese case of adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia caused by a de novo p.Phe849del mutation in CSF1R

2020 ◽  
Vol 8 (2) ◽  
pp. 96-98
Author(s):  
Kensuke Senzaki ◽  
Shiroh Miura ◽  
Masayuki Ochi ◽  
Takeaki Katoh ◽  
Yoko Okada ◽  
...  
Keyword(s):  
De Novo ◽  
Adult Onset ◽  
Axonal Spheroids ◽  
Japanese Case

scholarly journals Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia

2016 ◽  
Vol 38 (1) ◽  
pp. 77-83 ◽  
Author(s):  
T. Konno ◽  
D.F. Broderick ◽  
N. Mezaki ◽  
A. Isami ◽  
D. Kaneda ◽  
...  
Keyword(s):  
Diagnostic Value ◽  
Adult Onset ◽  
Axonal Spheroids

scholarly journals Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Caused by a Novel R782G Mutation in CSF1R

2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Nicola Foulds ◽  
Reuben J. Pengelly ◽  
Simon R. Hammans ◽  
James A. R. Nicoll ◽  
David W. Ellison ◽  
...  
Keyword(s):  
Adult Onset ◽  
Axonal Spheroids

Retraction: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: A case presented brain calcification and corpus callosum atrophy from over 10 years before the onset of dementia

2017 ◽  
Vol 57 (9) ◽  
pp. 521-526 ◽  
Author(s):  
Miyuki Okamoto ◽  
Jun Takeshita ◽  
Kazunori Takahashi ◽  
Akio Tanaka ◽  
Kunihiro Yoshida ◽  
...  
Keyword(s):  
Corpus Callosum ◽  
Adult Onset ◽  
Axonal Spheroids ◽  
Brain Calcification

scholarly journals An adult-onset leukoencephalopathy with axonal spheroids and pigmented glia accompanied by brain calcifications

2013 ◽  
Vol 260 (10) ◽  
pp. 2665-2668 ◽  
Author(s):  
Shinsuke Fujioka ◽  
Daniel F. Broderick ◽  
Christina Sundal ◽  
Matthew C. Baker ◽  
Rosa Rademakers ◽  
...  
Keyword(s):  
Adult Onset ◽  
Axonal Spheroids

scholarly journals Amyloid-β PET and CSF in an autopsy confirmed cohort

2020 ◽  
Author(s):  
Juhan Reimand ◽  
Baayla D.C. Boon ◽  
Lyduine E. Collij ◽  
Charlotte E. Teunissen ◽  
Annemieke J.M. Rozemuller ◽  
...  
Keyword(s):  
Granulomatosis With Polyangiitis ◽  
Amyloid Β ◽  
Emission Tomography ◽  
Adult Onset ◽  
Type B ◽  
Memory Clinic ◽  
Axonal Spheroids ◽  
Positron Emission ◽  
Neuropathological Diagnosis

AbstractObjectiveAccumulation of amyloid-β is among the earliest changes in Alzheimer’s disease (AD). Amyloid-β positron emission tomography (PET) and Aβ42 in cerebrospinal fluid (CSF) both assess amyloid-β pathology in-vivo, but 10–20% of cases show discordant (CSF+/PET- or CSF-/PET+) results. The neuropathological correspondence with amyloid-β CSF/PET discordance is unknown.MethodsWe included 21 patients from our tertiary memory clinic who had undergone both CSF Aβ42 analysis and amyloid-β PET, and had neuropathological data available. Amyloid-β PET and CSF results were compared with neuropathological ABC scores (comprising of Thal (A), Braak (B) and CERAD (C) stage, all ranging from 0 [low] to 3 [high]) and neuropathological diagnosis.ResultsNeuropathological diagnosis was AD in 11 (52%) patients. Amyloid-β PET was positive in all A3, C2 and C3 cases and in one of the two A2 cases. CSF Aβ42 was positive in 92% of A2/A3 and 90% of C2/C3 cases. PET and CSF were discordant in 3/21 (14%) cases: CSF+/PET- in a patient with granulomatosis with polyangiitis (A0B0C0), CSF+/PET- in a patient with FTLD-TDP type B (A2B1C1), and CSF-/PET+ in a patient with AD (A3B3C3). Two CSF+/PET+ cases had a non-AD neuropathological diagnosis, i.e. FTLD-TDP type E (A3B1C1) and adult-onset leukoencephalopathy with axonal spheroids (A1B1C0).InterpretationOur findings confirm amyloid-β CSF/PET discordance with a range of possible reasons. Furthermore, amyloid-β biomarker positivity on both PET and CSF did not invariably result in an AD diagnosis at autopsy, illustrating the importance of considering relevant co-morbidities when evaluating amyloid-β biomarker results.

Sign in / Sign up

Export Citation Format

Share Document